Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.
Credit Suisse Downgrades CoreSite Realty to Neutral, Raises Price Target to $170
Credit Suisse analyst Sami Badri downgrades CoreSite Realty (NYSE:COR) from Outperform to Neutral and raises the price target from $158 to $170.